NCT04740047
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting

Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Lung
Additional Notes: Patient must be a candidate for CT-guided needle biopsy
Exclusions: Patients with prior surgical intervention performed in the same lobe as the target nodule(s)
https://ClinicalTrials.gov/show/NCT04740047